stearylamine has been researched along with Neoplasm Metastasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, FQ; Li, Y; Liu, X; Shang, XW; Wang, L; Yuan, H; Zhou, XQ | 1 |
| Ali, N; Asad, M; Banerjee, I; De, M; Ghosh, S | 1 |
2 other study(ies) available for stearylamine and Neoplasm Metastasis
| Article | Year |
|---|---|
Inhibition of chemotherapy-related breast tumor EMT by application of redox-sensitive siRNA delivery system CSO-ss-SA/siRNA along with doxorubicin treatment.
Topics: Amines; Antineoplastic Agents; Breast Neoplasms; Chitosan; Doxorubicin; Drug Delivery Systems; Epithelial-Mesenchymal Transition; Female; Humans; MCF-7 Cells; Neoplasm Metastasis; Oxidation-Reduction; rac1 GTP-Binding Protein; Reactive Oxygen Species; RNA, Small Interfering | 2020 |
Combining doxorubicin with stearylamine-bearing liposomes elicits Th1 cytokine responses and cures metastasis in a mouse model.
Topics: Amines; Animals; Cell Line, Tumor; Cytokines; Disease Models, Animal; Doxorubicin; Female; Liposomes; Lung Neoplasms; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Spleen; Th1 Cells; Tumor Microenvironment | 2020 |